The inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via the Wnt/β-catenin pathway in esophageal squamous cell carcinoma [31]. The gene discussed is SALL4; the disease is esophageal squamous cell carcinoma.